BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 10940875)

  • 21. The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their microenvironment.
    Weinstein PD; Cebra JJ
    J Immunol; 1991 Dec; 147(12):4126-35. PubMed ID: 1753088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation.
    Hörnquist CE; Ekman L; Grdic KD; Schön K; Lycke NY
    J Immunol; 1995 Sep; 155(6):2877-87. PubMed ID: 7673704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of mucosal IgA production in vitro by autoreactive immunoregulatory T cells from murine Peyer's patches.
    Kawanishi H; Mirabella S
    Cell Immunol; 1988 Jul; 114(2):324-35. PubMed ID: 2898979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional dichotomy of interleukin-4 and -5 regulation of senescent B cell responses specific for cholera toxin in Peyer's patches, lamina propria, and mesenteric lymph nodes.
    Haq JA; Szewczuk MR
    Reg Immunol; 1993; 5(1):60-7. PubMed ID: 8347471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct roles for Peyer's patch B cells for induction of antigen-specific IgA antibody responses in mice administered oral recombinant Salmonella.
    Hashizume-Takizawa T; Shibata N; Kurashima Y; Kiyono H; Kurita-Ochiai T; Fujihashi K
    Int Immunol; 2019 Jul; 31(8):531-541. PubMed ID: 30868152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer's patch B cells of relevant and unrelated specificities to secrete IgG and IgA.
    Lebman DA; Fuhrman JA; Cebra JJ
    Reg Immunol; 1988; 1(1):32-40. PubMed ID: 3275128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses.
    Bergqvist P; Stensson A; Hazanov L; Holmberg A; Mattsson J; Mehr R; Bemark M; Lycke NY
    Mucosal Immunol; 2013 Jan; 6(1):122-35. PubMed ID: 22785230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin.
    Hahn A; Thiessen N; Pabst R; Buettner M; Bode U
    Immunology; 2010 Mar; 129(3):427-36. PubMed ID: 19922419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization.
    Van Der Stede Y; Verfaillie T; Cox E; Verdonck F; Goddeeris BM
    Clin Exp Immunol; 2004 Mar; 135(3):380-90. PubMed ID: 15008969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
    Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in specific B cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes.
    Cebra JJ; Fuhrman JA; Griffin P; Rose FV; Schweitzer PA; Zimmerman D
    Ann Allergy; 1984 Dec; 53(6 Pt 2):541-9. PubMed ID: 6209998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA responses in xid mice: oral antigen primes Peyer's patch cells for in vitro immune responses and secretory antibody production.
    Kiyono H; Mosteller LM; Eldridge JH; Michalek SM; McGhee JR
    J Immunol; 1983 Dec; 131(6):2616-22. PubMed ID: 6227659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.
    Gearhart PJ; Cebra JJ
    J Exp Med; 1979 Jan; 149(1):216-27. PubMed ID: 105075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation.
    Kjerrulf M; Grdic D; Kopf M; Lycke N
    Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria.
    Fagarasan S; Kinoshita K; Muramatsu M; Ikuta K; Honjo T
    Nature; 2001 Oct; 413(6856):639-43. PubMed ID: 11675788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.